These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16438672)

  • 1. Protective and pathogenic roles of CD8+ T cells during malaria infection.
    Hafalla JC; Cockburn IA; Zavala F
    Parasite Immunol; 2006; 28(1-2):15-24. PubMed ID: 16438672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector and memory CD8+ T cells as seen in immunity to malaria.
    Morrot A; Zavala F
    Immunol Rev; 2004 Oct; 201():291-303. PubMed ID: 15361248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection.
    Hafalla JC; Rai U; Bernal-Rubio D; Rodriguez A; Zavala F
    J Infect Dis; 2007 Dec; 196(12):1827-35. PubMed ID: 18190264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V; Romero JF; Kensil C; Corradin G
    Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actively induced antigen-specific CD8+ T cells by epitope-bearing parasite pre-infection but not prime/boost virus vector vaccination could ameliorate the course of Plasmodium yoelii blood-stage infection.
    Ono T; Yamaguchi Y; Oguma T; Takayama E; Takashima Y; Tadakuma T; Miyahira Y
    Vaccine; 2012 Sep; 30(44):6270-8. PubMed ID: 22902783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CD8+ and CD4+ T lymphocyte responses against malaria].
    Kuk S
    Mikrobiyol Bul; 2007 Apr; 41(2):329-39. PubMed ID: 17682721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Liver CD8 T Cell Subsets that are Associated with Protection Against Pre-erythrocytic Plasmodium Parasites.
    Zarling S; Krzych U
    Methods Mol Biol; 2015; 1325():39-48. PubMed ID: 26450377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection.
    Ocaña-Morgner C; Wong KA; Lega F; Dotor J; Borras-Cuesta F; Rodriguez A
    Eur J Immunol; 2007 Jun; 37(6):1562-74. PubMed ID: 17474154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
    Friesen J; Matuschewski K
    Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
    Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
    Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites.
    Butler NS; Schmidt NW; Harty JT
    J Immunol; 2010 Mar; 184(5):2528-38. PubMed ID: 20097864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
    Tartz S; Rüssmann H; Kamanova J; Sebo P; Sturm A; Heussler V; Fleischer B; Jacobs T
    Vaccine; 2008 Nov; 26(47):5935-43. PubMed ID: 18804138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An early commitment to expression of a particular TCRVbeta chain on CD8(+) T cells responding to attenuated Plasmodium berghei sporozoites is maintained following challenge with infectious sporozoites.
    Lumsden JM; Cranmer MA; Krzych U
    Parasite Immunol; 2010; 32(9-10):644-55. PubMed ID: 20691016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological responses of neonates and infants to DNA vaccines.
    Sedegah M; Hoffman SL
    Methods Mol Med; 2006; 127():239-51. PubMed ID: 16988458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.